Exhibit 31.2
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE13a-14(a) AND15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, J. Scott Wolchko, certify that:
1. I have reviewed this Amendment No. 1 to the quarterly report onForm 10-Q of Fate Therapeutics, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| Date: February 8, 2019 | /s/ J. Scott Wolchko | |||
| J. Scott Wolchko | ||||
| President and Chief Executive Officer | ||||
| (Principal Executive and Financial Officer) |
